The trajectory of Sildenafil presents a nuanced case for stakeholders in the drug sector. While initially a tremendous success, generating billions, the exclusivity end and the subsequent arrival of generic competitors https://knockoff812092.life3dblog.com/40174108/the-little-copyright-and-the-pharmaceutical-industry-a-speculative-investment